255 related articles for article (PubMed ID: 12696725)
1. Gastroesophageal reflux and histamine2 antagonists.
Bell SG
Neonatal Netw; 2003; 22(2):53-7. PubMed ID: 12696725
[No Abstract] [Full Text] [Related]
2. Clinical review of histamine2 receptor antagonists.
Lipsy RJ; Fennerty B; Fagan TC
Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
[TBL] [Abstract][Full Text] [Related]
3. The clinical use of histamine-2 receptor antagonists.
Michocki RJ; Richardson JP
Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
5. Ranitidine versus cimetidine in the healing of erosive esophagitis.
McCarty-Dawson D; Sue SO; Morrill B; Murdock RH
Clin Ther; 1996; 18(6):1150-60. PubMed ID: 9001831
[TBL] [Abstract][Full Text] [Related]
6. Bedtime treatment of duodenal ulcer.
Drug Ther Bull; 1985 Dec; 23(24):95-6. PubMed ID: 2866081
[No Abstract] [Full Text] [Related]
7. [Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?].
Paleev NR; Isakov VA; Ivanova OV
Klin Med (Mosk); 2005; 83(1):9-14. PubMed ID: 15759483
[No Abstract] [Full Text] [Related]
8. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
Vasil'ev IuV; Li IA
Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of oral famotidine and ranitidine on gastric volume and pH.
Dubin SA; Silverstein PI; Wakefield ML; Jense HG
Anesth Analg; 1989 Nov; 69(5):680-3. PubMed ID: 2572186
[No Abstract] [Full Text] [Related]
10. Ranitidine effervescent and famotidine wafer in the relief of episodic symptoms of gastro-oesophageal reflux disease.
Engzelius JM; Solhaug JH; Knapstad LJ; Kjaersgaard P
Scand J Gastroenterol; 1997 Jun; 32(6):513-8. PubMed ID: 9200279
[TBL] [Abstract][Full Text] [Related]
11. [The effect of H2-receptor blockers (cimetidine and ranitidin) on parotid gland secretion and salivary carbonic anhydrase activity in the rat].
Boros I; Keszler P; Szombath D; PĆ³sch E
Fogorv Sz; 1993 Aug; 86(8):265-73. PubMed ID: 7902302
[TBL] [Abstract][Full Text] [Related]
12. Famotidine in gastroesophageal reflux disease (GERD).
Wesdorp IC
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic thrombo-cytopenic purpura associated with histamine H2-receptor antagonist therapy.
Kallal SM; Lee M
West J Med; 1996 May; 164(5):446-8. PubMed ID: 8686308
[No Abstract] [Full Text] [Related]
14. Do H2 receptor antagonists have a therapeutic role in childhood?
Kelly DA
J Pediatr Gastroenterol Nutr; 1994 Oct; 19(3):270-6. PubMed ID: 7815256
[TBL] [Abstract][Full Text] [Related]
15. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
Mainguet P
Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
[No Abstract] [Full Text] [Related]
16. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
Tomasko MA; Luskin AT
Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
[No Abstract] [Full Text] [Related]
17. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
18. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
Thomas JM; Misiewicz G
Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
[No Abstract] [Full Text] [Related]
19. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
[TBL] [Abstract][Full Text] [Related]
20. Patience is a virtue in the management of gastroesophageal reflux.
Clark RH; Spitzer AR
J Pediatr; 2009 Oct; 155(4):464-5. PubMed ID: 19772996
[No Abstract] [Full Text] [Related]
[Next] [New Search]